chr16-1792314-T-TC
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_004970.3(IGFALS):c.103dupG(p.Glu35fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000131 in 1,597,134 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
IGFALS
NM_004970.3 frameshift
NM_004970.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.342
Genes affected
IGFALS (HGNC:5468): (insulin like growth factor binding protein acid labile subunit) The protein encoded by this gene is a serum protein that binds insulin-like growth factors, increasing their half-life and their vascular localization. Production of the encoded protein, which contains twenty leucine-rich repeats, is stimulated by growth hormone. Defects in this gene are a cause of acid-labile subunit deficiency, which maifests itself in a delayed and slow puberty. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SPSB3 (HGNC:30629): (splA/ryanodine receptor domain and SOCS box containing 3) Predicted to be involved in proteasome-mediated ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be part of SCF ubiquitin ligase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 19 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-1792314-T-TC is Pathogenic according to our data. Variant chr16-1792314-T-TC is described in ClinVar as [Pathogenic]. Clinvar id is 1068339.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFALS | NM_004970.3 | c.103dupG | p.Glu35fs | frameshift_variant | 2/2 | ENST00000215539.4 | NP_004961.1 | |
IGFALS | NM_001146006.2 | c.217dupG | p.Glu73fs | frameshift_variant | 2/2 | NP_001139478.1 | ||
IGFALS | NR_027389.1 | n.157dupG | non_coding_transcript_exon_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFALS | ENST00000215539.4 | c.103dupG | p.Glu35fs | frameshift_variant | 2/2 | 1 | NM_004970.3 | ENSP00000215539.3 | ||
IGFALS | ENST00000415638.3 | c.217dupG | p.Glu73fs | frameshift_variant | 2/2 | 2 | ENSP00000416683.3 | |||
IGFALS | ENST00000568221.1 | c.135dupG | p.Lys46fs | frameshift_variant | 2/2 | 4 | ENSP00000456923.1 | |||
SPSB3 | ENST00000569769.1 | c.-13+1322dupG | intron_variant | 3 | ENSP00000455098.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152122Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
4
AN:
152122
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000315 AC: 7AN: 222216Hom.: 0 AF XY: 0.0000323 AC XY: 4AN XY: 123804
GnomAD3 exomes
AF:
AC:
7
AN:
222216
Hom.:
AF XY:
AC XY:
4
AN XY:
123804
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000118 AC: 17AN: 1444894Hom.: 0 Cov.: 35 AF XY: 0.0000125 AC XY: 9AN XY: 719064
GnomAD4 exome
AF:
AC:
17
AN:
1444894
Hom.:
Cov.:
35
AF XY:
AC XY:
9
AN XY:
719064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152240Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74424
GnomAD4 genome
AF:
AC:
4
AN:
152240
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74424
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2022 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this premature translational stop signal affects IGFALS function (PMID: 27018247). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. ClinVar contains an entry for this variant (Variation ID: 1068339). This premature translational stop signal has been observed in individuals with acid-labile subunit deficiency (PMID: 20591980, 28445628). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs766644457, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Glu35Glyfs*17) in the IGFALS gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 571 amino acid(s) of the IGFALS protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at